Sun, May 26, 2013, 2:45 AM EDT - U.S. Markets closed
FDA just approved Signifor (Novartis) for Cushings. Is there room for 2 drugs in this rare indication? Root
No there is not room for both.hence why Novartis is gonna buyout CORT soo.
Sentiment: Strong Buy
I think most patients would prefer Corcept Therapeutics once a day oral opposed to Novartis's 2x a day injection!!! IMO
Sentiment: Buy